GMED · Globus Medical Inc
United States · RS rating 60 · As of 2026-11-03
| Price | 79.58 USD |
|---|---|
| 1-day change | +0.1% |
| RS rating (overall / 1M / 3M / 12M) | 60 / 69 / 64 / 76 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 32 / 29 / 39 |
| Industry group (rank) | Medical-Products (106) |
| EPS growth Q/Q | +17.1% |
| Sales growth Q/Q | +7.5% |
| Distance from 52-week high | +17.8% |
| Market cap (USD) | $12.8B |